• HPR51 Use of Real World Evidence in 2023 Novel Drug Approvals

    Jun 1, 2024, 00:00

  • EPH215 Recent Trends in the Incidence and Prevalence of Atopic Dermatitis in the United States: Eliciting Differences by Age and Sex

    Jun 1, 2024, 00:00

  • P35 Are Proposals for a Scheme to Stimulate Investment in Critically Needed New Antimicrobials Fit for Purpose?

    Jun 1, 2024, 00:00

  • RWD29 Predictive Model for Dementia in Patients with Type 2 Diabetes Using a Common Data Model

    Jun 1, 2024, 00:00

  • EPH5 COVID-19 Vaccine Acceptance Disparities Among Foreign-Born and US-Born Individuals in California: A 2021 Cross-Sectional Analysis

    Jun 1, 2024, 00:00

  • EE145 The Economic Impact of Overweight and Obesity-Related Diseases in Colombia

    Jun 1, 2024, 00:00

  • HPR78 Eliciting Inequality Aversion in the United States: Results from a Benefit Trade-Off Experiment

    Jun 1, 2024, 00:00

  • PCR174 Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review

    Jun 1, 2024, 00:00

  • MSR91 Assessing Recall in Abstract Screening: Artificial Intelligence Vs. Human Reviewers

    Jun 1, 2024, 00:00

  • EE97 Micro-Costing of Relapse and Refractory EGPA Treatment in Brazil Using the Lens of Experts

    Jun 1, 2024, 00:00

  • EPH48 Would Exposure to Metformin Reduce Mortality in Patients With Glioblastioma?

    Jun 1, 2024, 00:00

  • EPH105 Obesity Continues to be Associated With Poor Health-Related Quality of Life During the Third Year of the COVID-19 Pandemic

    Jun 1, 2024, 00:00

  • EE254 The Cost-Consequence of Budesonide/Formoterol Plus As-Needed Saba As Treatment for 6-12 Years Old Pediatric Asthma Patients in ChinaBased on Real-World Data

    Jun 1, 2024, 00:00

  • HPR103 Calcimimetic Prescriptions Following the Transitional Drug Add-on Payment Adjustment in Fee-for-Service Medicare Patients on Dialysis

    Jun 1, 2024, 00:00

  • EE103 Cost-Effectiveness of Universal Newborn Screening for Spinal Muscular Atrophy With Disease-Modifying Therapies in Taiwan

    Jun 1, 2024, 00:00

  • EE434 Benefits of a Polymer Tip in Torsional Phacoemulsification: A Targeted Literature Search and Budget Impact Model

    Jun 1, 2024, 00:00

  • RWD153 Best of Both Worlds: Enhancing Claims Data with Lab Results in Real-World Evidence Generation

    Jun 1, 2024, 00:00

  • EE5 Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database

    Jun 1, 2024, 00:00

  • EE291 Schizophrenia and Bipolar Disorder Burden and Economic Burden Under an Impact Analysis by Therapeutic Scheme

    Jun 1, 2024, 00:00

  • HPR92 Assessment of Surrogate Endpoints in Real-World Oncology Studies, a Systematic Literature Review

    Jun 1, 2024, 00:00

  • EE331 Clinical and Health Outcomes Associated With Different Treatment Sequences for Moderate-to-Severe Ulcerative Colitis

    Jun 1, 2024, 00:00

  • RWD71 The Burden of Haemophilia in 5 European Countries: Methods and Results from the Cost of Haemophilia in Europe: A Socioeconomic Survey (CHESS) 2022

    Jun 1, 2024, 00:00

  • EPH103 Fatal Outcomes from Drug Interactions: Insights from the FDA Adverse Event Reporting System

    Jun 1, 2024, 00:00

  • RWD62 Enriching the Value of Real-World Oncology Data With Important Clinical Information From Unstructured Data Sources for Better Clinical Insight Generation

    Jun 1, 2024, 00:00

  • HPR85 Estimating the Income Elasticity of Abortion: A Cross-National Study of 99 Countries

    Jun 1, 2024, 00:00

  • PCR257 Beliefs and Factors Associated With Intentions to Initiate Antihypertensive Medications

    Jun 1, 2024, 00:00

  • PCR155 Health-Related Quality of Life Among High School Students with Myopia in China

    Jun 1, 2024, 00:00

  • CO134 Association between Baseline Lung Function and Oral Corticosteroid Elimination in Patients with Oral Corticosteroid-Dependent Severe Asthma

    Jun 1, 2024, 00:00

  • EE10 The Impact of Spinal Muscular Atrophy Type 1 (SMA1) on Caregivers in Brazil: Results of a Global Survey

    Jun 1, 2024, 00:00

  • CO103 Antidepressant Adherence Using Group-Based Trajectory Modeling Among Postpartum Women With Texas Medicaid

    Jun 1, 2024, 00:00

  • EE174 Assessing the Cost-Effectiveness of an mRNA-Based Rsv Vaccine (mRNA-1345) Amongst Canadian Adults Aged ≥60 Years

    Jun 1, 2024, 00:00

  • PCR43 Health Utility Decrement of Injection Treatment-Related Attributes Among Type 2 Diabetes Patients in China

    Jun 1, 2024, 00:00

  • HPR31 A Targeted Literature Review To Identify the Dimensions of Sustainable Global Biosimilars Markets

    Jun 1, 2024, 00:00

  • EE1 Comparative Cost-Effectiveness Analysis of Interventions for Perinatal Methamphetamine Use Disorder: A Decision Modeling Method

    Jun 1, 2024, 00:00

  • HSD78 Prescribing Patterns of Novel Oral Therapies for Ulcerative Colitis in a Large Integrated Delivery Network

    Jun 1, 2024, 00:00

  • EPH227 Identifying Prediabetes Patients Using Administrative Claims Linked with Lab Data to Assess Progression to Type 2 Diabetes

    Jun 1, 2024, 00:00

  • MT5 Comparison of Outcomes of ePTFE Vascular Grafts With Heparin End-Point Covalent Bond and Alternative Autologous Vein for Below-Knee Surgical Bypass Procedures in Critical Limb Ischemia Patients

    Jun 1, 2024, 00:00

  • SA25 Diagnostic Test Accuracy of Serum Amylase and Lipase for Diagnosing Acute Pancreatitis: A Meta-Analysis

    Jun 1, 2024, 00:00

  • PCR143 Diagnostic Delay of Multiple Sclerosis in China: A Nationwide Cross-Sectional Study

    Jun 1, 2024, 00:00

  • HSD117 Causes and Characteristics of Drug Shortages in the United States

    Jun 1, 2024, 00:00

  • Patient-Centered Research

    Jun 1, 2024, 00:00

  • EE83 Total Costs and Cost Savings of Comprehensive Knee Osteoarthritis Management Combined With Total Knee Arthroplasty in an Ambulatory Surgical Center

    Jun 1, 2024, 00:00

  • PCR12 Exploring Patterns of Treatment Utilization and Promis Scores in a Home-Reported Outcomes Study for Individuals with Sickle Cell Disease (SCD)

    Jun 1, 2024, 00:00

  • HTA21 Organizations Responsible for the Evaluation of Health Technologies Globally: A Scoping Review

    Jun 1, 2024, 00:00

  • EE32 Determining the Expected Pricing Advantage of First-in-Indication and First-in-Class Non-Oncology Orphan Products

    Jun 1, 2024, 00:00

  • EE100 Exploring Frameworks and Methodologies to Incorporate Equity in Health Economics Evaluation: A Scoping Review

    Jun 1, 2024, 00:00

  • PCR9 Role of Video Versus Text Information in Willingness to be Vaccinated for Invasive Meningococcal Disease Among US Adolescents/Young Adults and Parents

    Jun 1, 2024, 00:00

  • RWD75 Machine Learning in Healthcare: Analyzing Cost Prediction Biases to Ensure Health Equity Among Older Adults With Incident Hodgkin’s Lymphoma

    Jun 1, 2024, 00:00

  • HPR9 Racial and Ethnic Inequities in Endometrial Cancer Survival From 2017 to 2022: Assessing the Influence of Social Determinants of Health

    Jun 1, 2024, 00:00

  • EE395 Cost-Effectiveness Analysis of Nivolumab Plus Relatlimab (NIVO+RELA) Versus Current Standard of Care (SOC) for Patients with Unresectable or Metastatic Melanoma in Canada

    Jun 1, 2024, 00:00

  • CO75 Clinical Outcomes Associated with Anti-CD38 Retreatment in Relapsed/Refractory Multiple Myeloma: A Review of the Literature

    Jun 1, 2024, 00:00

  • EE523 Costs Per Responder With Venetoclax in Combination With Azacitidine in Unfit Patients With Previously Untreated Acute Myeloid Leukemia in China

    Jun 1, 2024, 00:00

  • CO64 Prevalence of Immunosuppressants and Antifibrotic Use in Patients With Connective Tissue Disease-Related Interstitial Lung Disease

    Jun 1, 2024, 00:00

  • EPH79 HPV-Associated Cancers in Men: Epidemiological and Economic Burden in Costa Rica

    Jun 1, 2024, 00:00

  • RWD131 Replicating Published Real-World Evidence Studies Using Electronic Medical Records From Community Hospitals

    Jun 1, 2024, 00:00

  • EE481 Long-Term Cost-Effectiveness of Tirzepatide Versus Placebo for Individuals With Type 2 Diabetes and Obesity

    Jun 1, 2024, 00:00

  • CO74 Hospitalizations with Initiation of Hydroxychloroquine in Patients with Heart Failure with Preserved Ejection Fraction and Autoimmune Disease

    Jun 1, 2024, 00:00

  • MSR49 Long-Term Survival Prediction in Early Breast Cancer: A Machine Learning Approach With Random Survival Forest

    Jun 1, 2024, 00:00

  • EE409 An Applicable Method to Estimate the Broader Value of Antibiotics: Dynamic Transmission Model

    Jun 1, 2024, 00:00

  • Patient-Centered Research

    Jun 1, 2024, 00:00

  • OP12 Exploring Preferences in Selecting Dissertation Topics Among Ph.D. Students in Health Economics and Outcomes Research (HEOR) in the United States

    Jun 1, 2024, 00:00

  • EE380 Exploring the Impact of a Rare Disease (RD) Diagnosis on Work Productivity and Social Activity Impairment: A Systematic Literature Review (SLR) across Six Disease Areas

    Jun 1, 2024, 00:00

  • EE134 Budget Impact Analysis of Machine Learning Models for Diagnosing Alzheimer's Dementia

    Jun 1, 2024, 00:00

  • PCR259 No Value Without Equity: Transforming Power, People and Process for Equity in Health Technology Assessment

    Jun 1, 2024, 00:00

  • HSD88 The Impact of Diagnosing Provider Type on Longitudinal Care for Patients With Newly Diagnosed Huntington’s Disease (HD)

    Jun 1, 2024, 00:00

  • EE95 Value Comparison of BACT/ALERT®; VIRTUO® System Versus BD BACTEC™ FX Blood Culture System from a Provider Perspective

    Jun 1, 2024, 00:00

  • PCR42 Health State Utilities in Duchenne Muscular Dystrophy (DMD): A Longitudinal Study Using the EQ5D and Health Utilities Index (HUI)

    Jun 1, 2024, 00:00

  • P51 Characterization of Misdiagnosed Opsoclonus Myoclonus Ataxia Syndrome (OMAS)

    Jun 1, 2024, 00:00

  • MSR19 Methods for Relaxing the Proportional Odds Assumption in Meta-Analysis of Aggregate Data

    Jun 1, 2024, 00:00

  • PCR73 Health Care for People with Autism in the COVID-19 Pandemic

    Jun 1, 2024, 00:00

  • HPR106 Pricing of New Oncology Products in the US and Key European Markets

    Jun 1, 2024, 00:00

  • Perspectives on Improving Value Assessment With the ISPOR SUITABILITY Checklist [Editor's Choice]

    Jun 1, 2024, 00:00

  • EE120 Economic Burden of Pompe Disease in Colombia

    Jun 1, 2024, 00:00

  • EE137 Economic Burden for Adults With Sickle Cell Disease and Matched Controls in the United States: Retrospective Analysis of a Commercial Insurance Database

    Jun 1, 2024, 00:00

  • PCR18 Systematic Literature Review of Health Utility Values in Adult Patients with Post-Traumatic Stress Disorder

    Jun 1, 2024, 00:00

  • EE146 Comparative Analysis of the Burden of Illness Among Juvenile Idiopathic Inflammatory Myopathy Versus Juvenile Idiopathic Arthritis in the United States

    Jun 1, 2024, 00:00

  • EE302 Cost-Utility Analysis of Eptinezumab Versus Erenumab for Episodic Migraine Headaches Patients in the United States

    Jun 1, 2024, 00:00

  • P63 Comparative Analysis of Health Technology Assessment Agency Frameworks for Digital Health Technologies

    Jun 1, 2024, 00:00

  • HPR52 Disparity in New Cancer Drug Launches Worldwide: 1990-2022

    Jun 1, 2024, 00:00

  • EE421 Integrating Payer Reimbursement Strategies Into Modeling and Simulation (MS)-Based Methods to Redefine Drug Development

    Jun 1, 2024, 00:00

  • EE504 Cost-Effectiveness Analysis of Tremelimumab As First-Line Therapy for Metastatic Non-Small Cell Lung Cancer in Japan

    Jun 1, 2024, 00:00

  • RWD128 Herpes Zoster Infection in Adults With Rheumatic Diseases in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • HTA36 ATMP Reimbursement: A Targeted Review of Global HTA Assessment Trends

    Jun 1, 2024, 00:00

  • EPH223 Excess of Mortality By Asthma during COVID-19 Pandemic in Colombia

    Jun 1, 2024, 00:00

  • CO49 Progression of Chronic Kidney Disease Among Older Adults with Hypertension Using Group-Based Trajectory Modeling

    Jun 1, 2024, 00:00

  • MT12 Economic Outcomes of Polarstem Stem, R3 Acetabular Shell and Oxidized Zirconium Femoral Heads (POLAR3) Vs Non-POLAR3 Implant System in Total Hip Arthroplasty: A Real World Evidence Analysis

    Jun 1, 2024, 00:00

  • EPH82 Risk Perception of Tobacco and Nicotine Products: Which Consumer Reported Outcome Measures for Evidence Generation in Support of Regulatory Engagement?

    Jun 1, 2024, 00:00

  • MSR79 Evaluation of Real-World Response Rate in Clinical Trial-Aligned Cohorts of Patients With Lung, Colon, and Breast Cancer Using Machine Learning

    Jun 1, 2024, 00:00

  • HTA58 HTA Assessment of Single-Arm Trials: Comparison between the HAS and SMC

    Jun 1, 2024, 00:00

  • PCR88 Overall Retention and Characteristics Associated With Longitudinal Completion of Remote Patient-Reported Outcome Questionnaires in a Representative, General Population Cohort Study: The Project Baseline Health Study

    Jun 1, 2024, 00:00

  • PCR150 Burden of Invasive Meningococcal Disease in Survivors and Their Caregivers in the United States: A Cross-Sectional Non-Interventional Mixed Methods Study

    Jun 1, 2024, 00:00

  • MSR85 Efficacy of Modern Oral Antidiabetic Drugs: A Systematic Literature Review Network Meta-Analysis

    Jun 1, 2024, 00:00

  • CO78 Transfusion Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Transfusion-Dependent Beta-Thalassemia: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • HTA48 Systematic Review and Quality Assessment of Clinical and Economic Evidence For Superabsorbent Wound Dressings in a Population with Chronic Ulcers

    Jun 1, 2024, 00:00

  • SA21 Economic Analysis of Germline Genetic Testing to Assess for Hereditary Colorectal Cancer: A Systematic Review

    Jun 1, 2024, 00:00

  • EE178 Evaluating the Budget Impact of Introducing Preventive Therapy in the Preclinical Phase for Rheumatoid Arthritis : A Focus on Algerian Female Population at Risk

    Jun 1, 2024, 00:00

  • EPH228 Disability and Workers’ Compensation Absences Associated With Major Depressive Disorder and the Overlap With Family Medical Leaves Among United States Employees

    Jun 1, 2024, 00:00

  • EPH104 Public Health Impact of Pediatric BNT162b2 XBB1.5-Adapted COVID-19 Vaccine in the United States

    Jun 1, 2024, 00:00

  • RWD173 Using Population Data to Develop Precision Based Approaches to Hepatits C Prevention

    Jun 1, 2024, 00:00

  • PCR37 Differences in PHQ-9 Scores Based on Remote Digital Versus in-Person Administration: Findings From the Project Baseline Health Study

    Jun 1, 2024, 00:00

  • RWD130 European Health Data Space (EHDS) Requires Secure Processing Environments (SPEs) – Comparison of SPESiOR to Other SPE-Type Environments from Finnish, Nordic, European, and Global Settings

    Jun 1, 2024, 00:00

  • EE169 Cost to Achieve Seizures Reduction or Seizure Freedom in Dravet Syndrome in the USA: An Analysis Based on NNT (NUMBER NEEDED TO TREAT) of Stiripentol, Fenfluramine and Cannabidiol

    Jun 1, 2024, 00:00

  • HSD102 Job Preferences of Caregivers in Integrated Medical and Nursing Care Facilities: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • RWD45 Inequalities in the Costs and Affordability of a Healthy Diet in Europe between 2017 and 2021

    Jun 1, 2024, 00:00

  • P42 Budget Impact Analysis of Eculizumab Biosimilar for Treatment of Paroxysmal Nocturnal Hemoglobinuria from Public Hospital Perspective in 2023

    Jun 1, 2024, 00:00

  • EPH83 Mortality Rate By Tuberculosis in Colombia, 2012-2021: Regional Inequalities

    Jun 1, 2024, 00:00

  • EE381 Comparative Analysis of Patient Outcomes and Hospital Costs: Robotic-Assisted Surgery Versus Conventional Laparoscopic Surgery Across Five Procedures

    Jun 1, 2024, 00:00

  • CO83 Screening Articles in a Qualitative Literature Review Using Large Language Models: A Comparison of GPT Versus Open Source, Trained Models Against Expert Researcher Screening

    Jun 1, 2024, 00:00

  • MT9 Association of Neighborhood Disparity on Access to Tissue Surgical Heart Valves

    Jun 1, 2024, 00:00

  • HSD5 Real-World Treatment Patterns in Adults with Pemphigus Foliaceus in the United States

    Jun 1, 2024, 00:00

  • HTA74 Better Late Than Never? Payer Appetite and Vision for a National Value Assessment Body

    Jun 1, 2024, 00:00

  • HPR152 The Impact of Insurance Reform on Health Resource Utilization and Persistence for Chinese Patients With Crohn’s Disease, Taking Ustekinumab as an Example: Evidence From a Natural Experiment Study

    Jun 1, 2024, 00:00

  • EE375 Cost Savings and the Opportunity for Expanded Treatment Access with Increased Use of Biosimilar Adalimumab in the United States

    Jun 1, 2024, 00:00

  • P52 Burden of the Untreated Attacks and Its Impact on Social, Mental and Physical Health

    Jun 1, 2024, 00:00

  • RWD27 Creation of a Data Quality Framework for a United States Electronic Medical Record-Based Registry for Individuals with Spinal Muscular Atrophy

    Jun 1, 2024, 00:00

  • EE175 Economic Burden of Pneumococcal Disease Among US Children — A Review of Cost-Effectiveness Analyses of Pneumococcal Vaccines

    Jun 1, 2024, 00:00

  • PT42 A Systematic Literature Review and Meta-Analysis Comparing Robotic-Assisted Surgery Using the Da Vinci Surgical Systems for Benign Gynecological Procedures to Laparoscopic or Open Approach

    Jun 1, 2024, 00:00

  • RWD65 Characteristics of Real-World Databases in the United States: A Systematic Review

    Jun 1, 2024, 00:00

  • PCR251 A Conceptual Disease Model for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer (aGC/GEJC): Results From a Targeted Literature Review and Patient Interviews

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • P39 Quantifying Patient Preferences and Healthy-Time-Equivalents for Eosinophilic Esophagitis Treatments: A Stated-Preference Study

    Jun 1, 2024, 00:00

  • PCR113 Patients’ Perspectives on Bleeding, Bruising, and Other Key Changes Associated With Antithrombotic Treatment

    Jun 1, 2024, 00:00

  • HSD7 Territorial Inequalities in the Number of Cases Related to Benign Gynecological Disorders in Hungary

    Jun 1, 2024, 00:00

  • EE159 Price, Spending, and Utilization of Second-Generation Antipsychotics and the Impact of Generic Entry on Market Shares: Trend Analysis of Medicaid Database From 1991 to 2022

    Jun 1, 2024, 00:00

  • EE89 The Economic Impact of Anti-Scorpion Serum in the Management of Scorpion Envenomation in Algeria

    Jun 1, 2024, 00:00

  • CO29 Bruton's Tyrosine Kinase Inhibitors in B-Cell Lymphoma and Risk of Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Jun 1, 2024, 00:00

  • CO4 The Burden of Illness of Treatment-Induced Vasomotor Symptoms in Patients With Breast Cancer: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • HSD24 Impact of Telehealth on Health-Related Quality of Life in Depression: A Medical Expenditure Panel Survey Study

    Jun 1, 2024, 00:00

  • PCR157 Assessment of Patient Reported Outcomes in Chronic Versus Acute Disease: A Comparison of Study Design and Analytic Approaches

    Jun 1, 2024, 00:00

  • PCR22 Assessing the Implementation of the "Baby-Friendly Hospital Initiative” in Hungary

    Jun 1, 2024, 00:00

  • PCR10 Psychometric Evaluation and Estimation of Meaningful Change Thresholds of Patient-Reported Outcome Measures in Chronic Inducible Cold Urticaria

    Jun 1, 2024, 00:00

  • EE143 Estimating the Cost and Efficiency of Differentiated Direct-to-Pharmacy PrEP Refill Model in Kenya

    Jun 1, 2024, 00:00

  • RWD103 Treatment Patterns and Healthcare Resource Utilization Following Initiation of Aripiprazole Lauroxil Using a 1-Day Initiation Regimen

    Jun 1, 2024, 00:00

  • MSR70 Acceptance of Artificial Intelligence Augmented Systematic Reviews by Health Technology Assessment Bodies

    Jun 1, 2024, 00:00

  • PCR95 Are Patient-Reported Outcomes of Advanced Therapies Adequately Measured in the Real-World Settings in Ulcerative Colitis?

    Jun 1, 2024, 00:00

  • HSD127 Inappropriate Prescribing and Intent to Change Associated With Academic Detailing

    Jun 1, 2024, 00:00

  • MSR26 Exploring the Validity of Non-Responders As a Surrogate for Treatment Comparator Survival Outcomes in the Context of Histology Independent Therapies

    Jun 1, 2024, 00:00

  • EE239 Predictive Cost-Effectiveness Evaluation of Using a Machine Learning-Based Alzheimer’s Disease Risk Prediction Tool for Users of Social and Health Services Aged over 65 in Finland

    Jun 1, 2024, 00:00

  • RWD92 Contemporary Trends in Treatment Intensification for Men With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in 5 European Countries: Results From Patient Chart Reviews

    Jun 1, 2024, 00:00

  • OP19 Addressing RWE Challenges in Real-Time: The ‘Clean Room Committee’ Approach Works to Handle Research Hurdles without Bias

    Jun 1, 2024, 00:00

  • HPR95 Why It Is Important to Ensure the Price Is Right: Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy

    Jun 1, 2024, 00:00

  • PCR16 Clinical Actions Generated By Remote Symptom Alerts and Electronic Patient-Reported Outcomes (ePROs) in Real-World Breast Cancer Practice

    Jun 1, 2024, 00:00

  • MT3 US Payer Management of Digital Health Technologies: Recent Updates and a Glimpse into the Future

    Jun 1, 2024, 00:00

  • RWD48 Economic Burden Associated With Sobriety Restrictions to Direct-Acting Antiviral Access Among Medicaid Patients With Hepatitis C Virus: A Retrospective Analysis of Claims from States With and Without Restrictions

    Jun 1, 2024, 00:00

  • EE264 Cost-Effectiveness of GLP-1 Medications in Non-Diabetic Obesity Population

    Jun 1, 2024, 00:00

  • PCR71 Assessing Adherence to SGLT2 Inhibitor Add-on to Metformin Therapy in Chinese T2DM Patients: A Real-World Retrospective Cohort Study

    Jun 1, 2024, 00:00

  • PCR232 Do QALYs Discriminate Against the Elderly?

    Jun 1, 2024, 00:00

  • EPH37 Determinants of COVID-19 Vaccine Acceptance Among Nigerian Adults

    Jun 1, 2024, 00:00

  • EPH27 The Efficacy of Interventions Utilized in Communicating Risk Information to Improve Behavioral Outcomes Among Individuals Who Are Genetically Predisposed of Type 2 Diabetes: A Systematic Review

    Jun 1, 2024, 00:00

  • MSR13 What Most Concerns Patients about the Impact of Diabetes and Its Treatment on Their Ability to Drive?

    Jun 1, 2024, 00:00

  • EPH179 Patterns of Glucocorticoid Use Among Persons with Systemic Lupus Erythematosus (SLE) over Fifteen Years

    Jun 1, 2024, 00:00

  • EE498 What Are the Total Costs of Comprehensive Outpatient Management of Carpal Tunnel and Trigger Finger Using Time Driven Activity Based Costing Models?

    Jun 1, 2024, 00:00

  • CO71 Characterization of Physician-Reported Outcomes of People with HIV Switching Treatment: Findings from a Real-World Survey in the United States

    Jun 1, 2024, 00:00

  • HSD98 Benefits and Barriers to Same-Day Long-Acting Reversible Contraceptive Insertion: Evidence and Its Implications from US Settings

    Jun 1, 2024, 00:00

  • RWD19 Prescription and Reimbursement Patterns of Apixaban Post Launch: Inquiry into US Closed Claims Data for Association with Disease Severity

    Jun 1, 2024, 00:00

  • EPH25 Maternal Sexually Transmitted Infection Trends and Characteristics in the United States: 2018-2022

    Jun 1, 2024, 00:00

  • PCR25 New Zealanders’ Preferences for Community Pharmacies: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • RWD1 To Investigate Gender and Racial Disparities in the Resource Utilization of Patients With Lung Diseases in the US: A Real-World Data Study

    Jun 1, 2024, 00:00

  • OP5 Drug Launches Reflect Overall Company Performan Analysis Uncovers Lessons That Large Pharmaceutical Companies Could Glean from Their Smaller Rivals’ Drug Launch Strategies

    Jun 1, 2024, 00:00

  • A Methodological Study to Compare Alternative Modes of Administration With Value EQ-5D Using Preference-Elicitation Techniques

    Jun 1, 2024, 00:00

  • PCR183 Prevalence of Orthorexia Nervosa Among People on a Plant-Based Diet

    Jun 1, 2024, 00:00

  • HTA7 Access to Pan-Tumor Therapies in Oncology – Do US Patients Have an Advantage?

    Jun 1, 2024, 00:00

  • PCR27 Discrete Choice Experiment (DCE) Methodology Associated With a Multi-Phase Patient/Caregiver Preference Study in Growth Hormone Deficiency (GHD)

    Jun 1, 2024, 00:00

  • P36 Unsupported Policy Information? The Institute for Clinical and Economic Review's Unsupported Price Increase Reports

    Jun 1, 2024, 00:00

  • HSD3 Implications of Non-Medical Switching in Medicare Part D: An Updated Review of the Literature

    Jun 1, 2024, 00:00

  • PCR54 Monitoring Health-Related Quality of Life Following Dietary Supplementation With Folic Acid, Vitamin B12, and Vitamin D3 in Patients Diagnosed With Parkinson Disease in Romania

    Jun 1, 2024, 00:00

  • PCR163 Comparing Compliance By Race and Ethnicity for Schizophrenia Patients on Oral or Long-Acting Injectable Antipsychotics

    Jun 1, 2024, 00:00

  • EE512 Fluticasone Furoate/Umeclidinium/Vilanterol Vs Open Triple Therapy for Treating Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD) from a Brazilian Public Healthcare Perspective: A Budget Impact Analysis

    Jun 1, 2024, 00:00

  • Market Access on Availability and Use of Drugs

    Jun 1, 2024, 00:00

  • EE273 Impact of Mental Health Screening Access on Incremental Cost Estimates Among Patients with Postpartum Depression

    Jun 1, 2024, 00:00

  • MT33 Study Design Considerations for Digital Assessments in Parkinson’s Disease Clinical Trials

    Jun 1, 2024, 00:00

  • EE360 Association Between Public Health Partnership and Telehealth Infrastructure and Medicare Cost and Disparities Among Patients With Depression

    Jun 1, 2024, 00:00

  • MSR48 Utilization of High-Dimensional Propensity Score and Targeted Maximum Likelihood Estimation with Machine Learning to Improve Causal Effect Estimation in Patients with Nonvalvular Atrial Fibrillation and Hypertension

    Jun 1, 2024, 00:00

  • CO177 The Effect of Newly Approved Obesity Medications on Cardiovascular Complications

    Jun 1, 2024, 00:00

  • P47 GPT: The Next Frontier in Health Economic Modeling?

    Jun 1, 2024, 00:00

  • EE455 Cost-Effectiveness Analysis of Elacestrant in ER+/HER2- Advanced Breast Cancer Patient from US Payer Perspective

    Jun 1, 2024, 00:00

  • HSD63 Trends of Outpatient Medication Adherence Among Patients with Type 2 Diabetes in China

    Jun 1, 2024, 00:00

  • EE465 Modeling the Effects of Improving Varicella Vaccination Coverage Rates on Clinical and Economic Outcomes in Peru Over a 10-Year Time-Horizon

    Jun 1, 2024, 00:00

  • MT41 Outcomes and Costs Associated With Cervical Spinal Fusion Surgery

    Jun 1, 2024, 00:00

  • HTA10 Unveiling the Impact of Spironolactone in Women With PCOS: Beyond Its Anti-Androgen Properties - Insights From a Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • HTA15 European Health Technology Assessment: Historical Success of European Joint Assessments

    Jun 1, 2024, 00:00

  • RWD98 Real-World Management of Prurigo Nodularis: Epidemiological and Comorbidity Data in China

    Jun 1, 2024, 00:00

  • EE246 Consideration of the Cost of Adverse Events for Oncology Treatment: A Review of Cost-Effectiveness Evaluations in Japan

    Jun 1, 2024, 00:00

  • EE96 An “R-Shiny” Tool for Estimating Transition Probabilities From Various Published Literature for Health Economic Models

    Jun 1, 2024, 00:00

  • EE477 Reductions in Real-World Healthcare Resource Utilization Among United States Hereditary Angioedema (HAE) Patients Following Berotralstat Initiation

    Jun 1, 2024, 00:00

  • EPH140 Comparative Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular Weight Heparins in Cancer Associated Thrombosis

    Jun 1, 2024, 00:00

  • RWD181 Healthcare Costs Associated With Newly Diagnosed Type 1 Diabetes in Children With Commercial Health Plan or Medicaid Coverage in US Clinical Practice

    Jun 1, 2024, 00:00

  • Epidemiology Public Health

    Jun 1, 2024, 00:00

  • EE147 Healthcare Resource Utilization of Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF): A Retrospective Claims Analysis

    Jun 1, 2024, 00:00

  • HTA56 ICER Vs NICE – What Are Your Key Considerations for Health Technology Assessments for Rare Disease Therapies? Insights from a Review of Completed Assessments (2017-PRESENT)

    Jun 1, 2024, 00:00

  • MT22 Mapping Definitions of Patient-Facing Digital Health Intervention in Published Frameworks Against the PICOTS-ComTeC Minimum Information Framework

    Jun 1, 2024, 00:00

  • HSD8 Homologous Recombination Repair Testing Patterns and Barriers in Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer across Europe: A Real-World Survey

    Jun 1, 2024, 00:00

  • PCR60 Assessment of Quality of Life in Type II Diabetic Patients

    Jun 1, 2024, 00:00

  • EE348 Optimizing Economic Modelling Approaches in Health Disparities Research: Essential Insights

    Jun 1, 2024, 00:00

  • RWD127 Combining Patients’ Perspectives and Treatment/ Healthcare Resource Utilization in Chronic Lymphocytic Leukemia Using a Novel Real-World Patient-Centered Database

    Jun 1, 2024, 00:00

  • CO92 Comparative Effectiveness of Second-Line Immune Targeted Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Network Meta-Analysis

    Jun 1, 2024, 00:00

  • EE20 Cost Saving Analysis of Implementing Subcutaneous Formulation of Atezolizumab in a Danish Context (CS-ASSIST)

    Jun 1, 2024, 00:00

  • EE116 Budget Impact Model Framework of Positron Emission Tomography Compared to Single Photon Emission Computed Tomography Myocardial Perfusion Imaging for Coronary Artery Disease Diagnosis

    Jun 1, 2024, 00:00

  • PCR241 Behavioral Economics-Based Financial and Social Incentives for Weight Loss in Newly Diagnosed Type 2 Diabetes: A Randomized Control Trial

    Jun 1, 2024, 00:00

  • EE68 A UK Cost-Utility Analysis of Ferric Carboxymaltose Versus Ferric Derisomaltose in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease: Incorporation of Fracture Data

    Jun 1, 2024, 00:00

  • MSR75 Guidance or Misdirection? Unpacking the Role of Feedback in Health Preference Assessments

    Jun 1, 2024, 00:00

  • RWD47 Epidemiology of Epidermolysis Bullosa in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • EE451 Advancing Economic Evaluation Models in Colorectal Cancer Screening: A Comprehensive Methodological Review

    Jun 1, 2024, 00:00

  • EPH208 Prevalence and Average Annual Percent Change of Potentially Inappropriate Medication Use in Older Adults before and during the COVID-19 National Emergency

    Jun 1, 2024, 00:00

  • EE26 Economic Burden of Acquired Hemophilia- A Systematic Literature Review

    Jun 1, 2024, 00:00

  • PCR176 Preferences for a Combination Influenza and COVID-19 Vaccine: Results from a Threshold Technique Study with Consumers in the United Kingdom

    Jun 1, 2024, 00:00

  • EE12 Hypertension-Associated Medical Expenditures Among Privately Insured US Individuals Aged 18 to 64 Years in 2021

    Jun 1, 2024, 00:00

  • HSD72 Baseline A1C and BMI Trends for People with Type 2 Diabetes Receiving First-Time GLP-1 Ra Prescriptions

    Jun 1, 2024, 00:00

  • HTA51 Machine Learning Approaches to Reduce Economic Impact of Effective Interventions

    Jun 1, 2024, 00:00

  • EPH154 Impact of COVID-19 Response on Primary Care Utilization

    Jun 1, 2024, 00:00

  • MSR8 Validating the Time-Use Algorithm To Estimate Productivity Loss in Persons With Multiple Sclerosis

    Jun 1, 2024, 00:00

  • PCR242 Electronic Collection of Patient-Reported Outcome Measures in Dermatology Trials

    Jun 1, 2024, 00:00

  • SA1 Methods for Incorporating Non-Randomized Evidence From Single-Arm Trials Into Network Meta-Analysis (NMA): A Case Study in Recurrent/Metastatic Head and Neck Cancer (R/M-HNSCC)

    Jun 1, 2024, 00:00

  • EE59 Advancing Value of Information Methods: Does Conducting Further Research Directly Translate Into Changes in Clinical Practice, or Do Implementation Rates of Interventions Depend on the Levels and Types of Information Generated?

    Jun 1, 2024, 00:00

  • MT18 Public Perspectives on Emerging Multi-Cancer Early Detection (MCED) Tests: A Qualitative Study

    Jun 1, 2024, 00:00

  • CO33 Risk Factors for Increased Initial Hospital Length of Stay and 30-Day Readmissions in Patients with Relapsed/Refractory Large B-Cell Lymphoma Treated with Chimeric Antigen Receptor T-Cell Therapy at an Academic Cancer Center

    Jun 1, 2024, 00:00

  • RWD42 Epidemiology, Healthcare Resource Utilization, and Costs of Ulcerative Colitis and Crohn's Disease Patients in Taiwan: A National Health Insurance Research Database (NHIRD) Study

    Jun 1, 2024, 00:00

  • RWD161 Therapeutic Drug Monitoring (TDM) of Infliximab Is Associated with Lower Biologic Switch Expenditures Compared to No-TDM Cohort of IBD Patients Based on 12 to 48-Month Real-World Outcomes from a US Community GI Practice

    Jun 1, 2024, 00:00

  • CO6 Clinical Characterization of Patients with Wilson Disease (WD) Using Performance and Qulaitative Measures

    Jun 1, 2024, 00:00

  • MT17 Patient Characteristics Associated with Intentions to Use a Blood Pressure Telemonitoring Device Among Adults with Hypertension in the United States

    Jun 1, 2024, 00:00

  • PCR107 Health-Related Quality of Life and Utility Values Among Patients With Anxiety and/or Depression in a Low-Income Tertiary Care Setting: A Cross-Sectional Analysis

    Jun 1, 2024, 00:00

  • SA8 Methodological Approaches to Compare Treatment Options for Chronic Hepatitis D: An Early Network Meta-Analysis

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • EPH234 Real-World Clinical Characteristics and Disease Management of Immunoglobulin a Nephropathy Patients Across the United States

    Jun 1, 2024, 00:00

  • RWD184 Impact of Cardiovascular Medications on Non-Traumatic Amputation Rates in Type 2 Diabetes: Insights from a Large-Scale Retrospective Real-World Data Analysis

    Jun 1, 2024, 00:00

  • MT45 Analytical Performance, Quality of Life and Costs Related to Allergy Testing: Results from Two Systematic Literature Reviews

    Jun 1, 2024, 00:00

  • RWD17 Evaluating the Use of Antipsychotic Drug and Incidence of Stroke Among Patients With Dementia in the USA

    Jun 1, 2024, 00:00

  • EE280 Price Trends and Analysis of Targeted Immunomodulatory (TIM) Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Therapy

    Jun 1, 2024, 00:00

  • EPH156 Multimorbidity and Its Associations with Adverse Cardiovascular Events and Healthcare Costs Among Patients with Atherosclerotic Cardiovascular Disease: A Real-World Evidence Study

    Jun 1, 2024, 00:00

  • EE339 The Biosimilars’ Economic Evaluation in Contrast With Judicializations’ Economic Impacts of the Pharmaceutical Assistance in Brazil

    Jun 1, 2024, 00:00

  • PCR86 Depression Severity Among Pregnant Patients By Antidepressant Use during Pregnancy

    Jun 1, 2024, 00:00

  • CO149 Comparative Examination of Performance Metrics in Football and Handball Players within Controlled Laboratory Environments

    Jun 1, 2024, 00:00

  • PCR195 Assessing Time Trade-Off Utilities in Health States of Chronic Rhinosinusitis with Nasal Polyps: A Pilot Study in Brazil

    Jun 1, 2024, 00:00

  • EE422 “This Isn’t a Life”: An Analysis of EQ-5D in a Cohort of Individuals with Long COVID Symptoms

    Jun 1, 2024, 00:00

  • CO34 Glucagon-like Peptide-1 (GLP-1) Receptor Agonists - Efficacy, Safety, and Cost-Effectiveness in Obesity Management: A Systematic Review

    Jun 1, 2024, 00:00

  • EE349 Cost-Effectiveness of First-Line Treatment With Pembrolizumab for Unresectable or Metastatic MSI-H/dMMR Colorectal Cancer (CRC) in the United States Based on 5-Year Follow-up Data

    Jun 1, 2024, 00:00

  • EPH144 Exploring the Effectiveness and Engagement of Local Communities in Maternity Care Models for Women with Refugee and Migrant Backgrounds and Its Impact on Enhancing Perinatal Health Outcomes: A Comprehensive Systematic Review

    Jun 1, 2024, 00:00

  • EE114 A Systematic Review of Cost-Effectiveness Analyses of Gene Therapy Treatments for Hemophilia Type A and B

    Jun 1, 2024, 00:00

  • EE494 A Budget Impact Analysis of Newer Pneumococcal Conjugate Vaccine Use in All US Adults Aged 50-64 Years Old Compared to Current Recommendations from US Payer Perspective

    Jun 1, 2024, 00:00

  • MT31 The Role of Parental Self-Efficacy, Capability Well-Being and Electronic Health Literacy in Pediatric Diabetes Management: Insights from a Longitudinal Analysis of Glucose Sensor Data

    Jun 1, 2024, 00:00

  • CO15 The Hungarian Nurses Knowledge about Palliative Care

    Jun 1, 2024, 00:00

  • HPR90 Equity Effects of Public Health Insurance on Hypertension in Peru: Insights from a Panel Analysis of the Peruvian Demographic and Health Survey 2013-2019

    Jun 1, 2024, 00:00

  • EE402 Comparing the Expenditure and Health-Related Quality of Life between SGLT2 Inhibitors and GLP-1 Agonists

    Jun 1, 2024, 00:00

  • PCR261 Adherence to Endocrine Therapies Among Women With Non-Metastatic Breast Cancer in Developing Countries

    Jun 1, 2024, 00:00

  • EE287 Annual Treatment Cost of Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis

    Jun 1, 2024, 00:00

  • CO119 Indirect Treatment Comparison and Cost-Minimization Analysis between Riociguat and Selexipag to WHO Functional Class III Pulmonary Arterial Hipertension (PAH) Patients

    Jun 1, 2024, 00:00

  • CO47 A Novel Approach to Estimating the Risk of Harm Due to Drug-Drug Interactions: An Exemplary Model With Common Mediations That Interact With Oral Anticoagulants

    Jun 1, 2024, 00:00

  • RWD142 A Retrospective Analysis of Impact of Triptans and CGRP on Monthly Migraine Days (MMD) in Migraine Patients in the USA

    Jun 1, 2024, 00:00

  • MT7 Measures of ‘Life-Sustaining Medical-Technology’ for Caregivers of Children with Medical Complexity (CO-CMC)

    Jun 1, 2024, 00:00

  • MSR11 Can We Predict the Impact of the Differential Sensitivity of Health-Related Quality of Life (HRQoL) Instruments on the Valuation of Health State Changes?

    Jun 1, 2024, 00:00

  • EE346 Expanding Cost-Effectiveness Analysis to Demonstrate Population-Level Treatment Impact on Patients and Society

    Jun 1, 2024, 00:00

  • EE379 Assessing Trends in the Distribution of Prescription Claim Payments (2011-2021) and Implications for Retail Pharmacies

    Jun 1, 2024, 00:00

  • PCR169 Drivers of Depression and Anxiety in US Non-Segmental Vitiligo Patients

    Jun 1, 2024, 00:00

  • RWD139 Enhancing Public Health Through Timely Detection: Assessing the Value of Real-World Evidence With a Cardiovascular Defibrillator Leads Case Study

    Jun 1, 2024, 00:00

  • PCR210 Impact of Advanced/Metastatic Non–Small Cell Lung Cancer (A/MNSCLC) on Patients in the US and UK: Survey Results

    Jun 1, 2024, 00:00

  • PCR224 Development and Validation of a Tool to Predict Short Term Opioid Overdose Risk after Acquiring a Prescribed Controlled Substance

    Jun 1, 2024, 00:00

  • EE131 Cost Savings Associated With Use of 3D Heads-up Display (3D-HUD) in Macular Hole Surgeries: An Academic Hospital Perspective

    Jun 1, 2024, 00:00

  • EE313 Economic Impact of Cancer Related to Human Papilloma Virus in Ecuador

    Jun 1, 2024, 00:00

  • PCR263 Health Utility Decrement of Treatment-Related Attributes for Type 2 Diabetes Patients in China

    Jun 1, 2024, 00:00

  • EE167 Cost-Effectiveness Evaluations of CAR-T Cell Therapies By Health Technology Assessment Agencies

    Jun 1, 2024, 00:00

  • MSR77 Incorporating Cure Effect into Copula Models for Long-Term Survival Projections: A Case Study in Previously Treated Advanced Esophageal Squamous Cell Carcinoma (aESCC)

    Jun 1, 2024, 00:00

  • EE508 Cost-Effectiveness Analysis of Pembrolizumab for Advanced Colorectal Cancer with MSI-High or dMMR in Japan

    Jun 1, 2024, 00:00

  • CO23 Predicting Moderate-to-Severe Plaque Psoriasis From Prescription and Procedure Electronic Health Record Data

    Jun 1, 2024, 00:00

  • EE330 Analysis of Public Expenditure of Pharmaceutical Utilization of Female Infertility in Hungary between 2015-2022

    Jun 1, 2024, 00:00

  • RWD32 Advanced Prostate Cancer Decision Support through C PREFS (CANCER PREFERENCE REFLECTION AND ELICITATION FOR FAMILY SUPPORT)

    Jun 1, 2024, 00:00

  • EE37 Lifetime Survival, Societal Costs and Cost-Effectiveness of Nine Options to Treat Alcohol Use Disorder

    Jun 1, 2024, 00:00

  • EE453 Research and Clinical Delivery Costs of a Mobile Health Approach for Hypertension Management in Uncontrolled Hypertensive African Americans: A Cost Analysis

    Jun 1, 2024, 00:00

  • PCR193 Estimating Health State Utilities from a Longitudinal SMA Cohort

    Jun 1, 2024, 00:00

  • MSR82 Implementation and Validation of the Use of N-Gram Models for Classifying Social Determinants of Health Status from Real World Unstructured Clinical Notes

    Jun 1, 2024, 00:00

  • EPH116 Factors Influencing the Use of Second-Generation Antipsychotics in Patients With Autism Spectrum Disorders

    Jun 1, 2024, 00:00

  • EE397 Health and Budget Impact of Liquid Biopsy (LBx)-Based Comprehensive Genomic Profiling (CGP) in Patients With Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC)

    Jun 1, 2024, 00:00

  • RWD13 Epidemiology of Acute Cholecystitis in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • P31 Improving Long-Term Survival Assessment in Cost-Effectiveness Analyses: Examining Excess Hazard Methods and Cure Models in Non-Small Cell Lung Cancer Study

    Jun 1, 2024, 00:00

  • SA17 Adaptation of the Glucocorticoid Toxicity Index-Metabolic Domains to Electronic Health Records to Evaluate Steroid Toxicity in Adults with Myasthenia Gravis in the United States

    Jun 1, 2024, 00:00

  • EPH162 Characterizing Antimicrobial Resistance Post-Hospitalization: A Retrospective Analysis Using Administrative Claims Data

    Jun 1, 2024, 00:00

  • RWD188 Healthcare Cost and Healthcare Resource Utilization (HCRU) Among First-Line (1L) Treated Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC): Analysis of Seer-Medicare Linked Claims in the US

    Jun 1, 2024, 00:00

  • EE325 Cost-Effectiveness Analyses of Immune Checkpoint Inhibitors in Renal Cell Carcinoma: A Scoping Review

    Jun 1, 2024, 00:00

  • HPR26 Reimbursement of Medical Devices for Home Care: Worldwide Scenario, Challenges and Proposed Solutions

    Jun 1, 2024, 00:00

  • MSR74 The Effect of Applying a Demand Forecasting Model to Assess the Accuracy of Inventory Management in a Specialty Pharmacy

    Jun 1, 2024, 00:00

  • EE67 Health Economic Evaluation As a Tool for Sustainable Financing of the Unified Health System: The Case of Hemodialysis

    Jun 1, 2024, 00:00

  • EPH28 Public Health Impact of Switching From a 13-Valent to a 15-Valent Pneumococcal Conjugate Vaccine in the Chilean National Immunization Program

    Jun 1, 2024, 00:00

  • SA64 One-Step Parametric Network Meta-Analysis Models Using the Exact Likelihood That Allow for Time-Varying Treatment Effects

    Jun 1, 2024, 00:00

  • MT16 What Is the Medical Technology HTA Process in Japan?

    Jun 1, 2024, 00:00

  • EE244 Estimating Treatment Cost Savings of Gender-Neutral Nonavalent HPV Vaccination in Mexico

    Jun 1, 2024, 00:00

  • EE430 Does One Comparator Fit All Scenarios? An Example from the Institute for Clinical and Economic Review’s 2023 Assessment of Relapsing-Remitting Multiple Sclerosis

    Jun 1, 2024, 00:00

  • EE407 Treatment Patterns and Healthcare Resource Utilization in Ruxolitinib-Treated Patients with Myelofibrosis with and without Anemia: A Real-World Analysis

    Jun 1, 2024, 00:00

  • PT41 Comparative Analysis of Reintervention Rates in Mesh Versus No Mesh Hernia Repair Using Electronic Health Records

    Jun 1, 2024, 00:00

  • EE189 A Budget Impact Analysis of Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes Being Treated with Standard of Care in Tertiary Hospital, Riyadh, Saudi Arabia

    Jun 1, 2024, 00:00

  • MSR92 Quantitative Bias Analysis Under the Marginal Structural Modelling Framework

    Jun 1, 2024, 00:00

  • EE270 Cost-Utility Analysis of Add-on Stiripentol Vs Cannabidiol and Vs Fenfluramine in Dravet Syndrome in the USA

    Jun 1, 2024, 00:00

  • EPH110 Real-World Treatment Patterns in Adults Living With Primary Chronic Immune Thrombocytopenia in the United States

    Jun 1, 2024, 00:00

  • EE276 Understanding Trends in Launch Prices across Canada, EU4, UK and the US for High-Revenue Drugs

    Jun 1, 2024, 00:00

  • PCR128 Sustainable Food Consumption Patterns Among Adults in Hungary

    Jun 1, 2024, 00:00

  • CO210 An Updated Systematic Review and Network Meta-Analysis on Risks of Respiratory Tract Infections with Biologic and Targeted Synthetic Antirheumatic Agents in Psoriatic Arthritis

    Jun 1, 2024, 00:00

  • EE428 Budget Impact of Elranatamab-bcmm in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States

    Jun 1, 2024, 00:00

  • EPH126 A Systematic Review of the Application of Health Behavioral Theories in Drug Disposal and Reuse

    Jun 1, 2024, 00:00

  • EE524 Economic Evaluation of Pronase Granules for Gastric Cancer Screening in High-Risk Population in China

    Jun 1, 2024, 00:00

  • EE443 Work Loss Associated with Adult Vaccinations in Pharmacy and Healthcare Professional Office Settings in the United States

    Jun 1, 2024, 00:00

  • PCR116 Knowledge about Osteoporosis and Risk of Consequent Bone Fracture Among the Elderly People

    Jun 1, 2024, 00:00

  • EE90 Diagnostic Yield and Downstream Lung Cancer Treatment Revenue From Shape-Sensing Robotic-Assisted Bronchoscopy Compared to Transthoracic Needle Aspiration Biopsy

    Jun 1, 2024, 00:00

  • HSD33 Contraceptive Use Among Female Patients Who Underwent Bariatric Surgery in the U.S. Commercial Insurance Plans

    Jun 1, 2024, 00:00

  • PCR161 A Qualitative Study on Respondents’ Interpretation of the EQ-VAS in Ethiopia

    Jun 1, 2024, 00:00

  • CO22 Health-Related Quality of Life from a Phase 4 Global Clinical Study to Evaluate Discontinuation and Rechallenge of Pexidartinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) Previously Treated with Pexidartinib

    Jun 1, 2024, 00:00

  • SA16 Estimating Infant Date of Birth in Administrative Claims Databases: A Comparison of Exact Date of Birth and Date of Birth Proxies

    Jun 1, 2024, 00:00

  • PCR129 Indirect Effects of Music Therapy for Aphasia

    Jun 1, 2024, 00:00

  • MSR56 Navigating Uncertainty: Trends in ICER’s Evidence Ratings

    Jun 1, 2024, 00:00

  • EE347 JAV-RARAS: Preliminary Results of Measuring Adherence to the Phenylketonuria Treatment Protocol in Brazil

    Jun 1, 2024, 00:00

  • EPH55 An Updated View on the Initial Opioid Prescription Characteristics and Pain Etiologies That Influence Long-Term Opioid Use Among Opioid Naïve Patients

    Jun 1, 2024, 00:00

  • HPR118 Are We Closing the Gap? A Review of Health Equity Focused Interventions Along the Liver Cancer Care Cascade in the US

    Jun 1, 2024, 00:00

  • EE65 Cost-Effectiveness of Remote Patient Monitoring for Hypertension Management Among Older Adults with Hypertension: A Semi-Markov Modeling Study

    Jun 1, 2024, 00:00

  • PCR80 Make Her Voice Count: Understanding the Use of Patient-Reported Outcomes in Contraceptive Trials

    Jun 1, 2024, 00:00

  • HSD2 Switching From Anti-VEGF to Corticosteroid Implant Therapy in Diabetic Macular Edema Patients

    Jun 1, 2024, 00:00

  • PCR130 Comparison of the Quality of Life and Socio-Demographic Characteristics of Women with Physical Disabilities

    Jun 1, 2024, 00:00

  • HTA5 Examining the Impact of Eams on NICE Recommendations over the Past Four Years

    Jun 1, 2024, 00:00

  • Editorial Board

    May 3, 2024, 11:02

  • A Systematic Review of Value Criteria for Next-Generation Sequencing/Comprehensive Genomic Profiling to Inform Value Framework Development

    May 1, 2024, 00:00

  • Is the Comparator in Your Diagnostic Cost-Effectiveness Model “Standard of Care”? Recommendations from Literature Reviews and Expert Interviews on How to Identify and Operationalize It

    May 1, 2024, 00:00

  • Economic Evaluations of Establishing Opioid Overdose Prevention Centers in 12 North American Cities: A Systematic Review

    May 1, 2024, 00:00

  • Meaningful Change Thresholds and Fatigue Severity Points on Patient-Reported Outcomes by the Fatigue Symptoms and Impacts Questionnaire in Patients With Relapsing Multiple Sclerosis

    May 1, 2024, 00:00

  • Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study

    May 1, 2024, 00:00

  • Acceptability of Using Real-World Data to Estimate Relative Treatment Effects in Health Technology Assessments: Barriers and Future Steps [Editor's Choice]

    May 1, 2024, 00:00

  • It Is Time to Reconsider the 3% Discount Rate [Editor's Choice]

    May 1, 2024, 00:00

  • Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study [Editor's Choice]

    May 1, 2024, 00:00

  • Development and Valuation of a Preference-Weighted Measure in Age-Related Macular Degeneration From the Vision Impairment in Low Luminance Questionnaire: A MACUSTAR Report

    May 1, 2024, 00:00

  • Mapping Health Technology Assessment Agency Approaches for Biosimilar Value Assessment: An ISPOR Special Interest Group Report [Editor's Choice]

    May 1, 2024, 00:00

  • Table of Contents

    May 1, 2024, 00:00

  • Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies

    May 1, 2024, 00:00

  • Public Acceptance of Measures to Control Infectious Diseases Under Different Scenarios of Severity and Transmissibility [Editor's Choice]

    May 1, 2024, 00:00

  • EQ-5D-5L Population Norms and Quality-Adjusted Life Expectancy by Sociodemographic Characteristics and Modifiable Risk Factors for Adults in Queensland, Australia

    May 1, 2024, 00:00

  • Toward the Implementation of a Value Framework for Diagnostic Technologies: Operationalization, Piloting, and Validation in Latin America

    May 1, 2024, 00:00

  • Editorial Board

    Apr 1, 2024, 08:56

  • The Cost of Atrial Fibrillation: A Systematic Review

    Apr 1, 2024, 00:00

  • Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework [Editor's Choice]

    Apr 1, 2024, 00:00

  • Evaluating Recall Periods for Patient-Reported Outcome Measures: A Systematic Review of Quantitative Methods

    Apr 1, 2024, 00:00

  • Validation of China Health-Related Outcomes Measures-Cardiovascular Disease

    Apr 1, 2024, 00:00

  • Cost of Illness of Head and Neck Cancer in Sweden

    Apr 1, 2024, 00:00

  • Economic Evaluation of an Enhanced Post-Discharge Home-Based Care Program for Stroke Survivors

    Apr 1, 2024, 00:00

  • The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report

    Apr 1, 2024, 00:00

  • Exploring the Comparability Between EQ-5D and the EQ Health and Wellbeing in the General Australian Population

    Apr 1, 2024, 00:00

  • The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation

    Apr 1, 2024, 00:00

  • Table of Contents

    Apr 1, 2024, 00:00

  • A Comparison of Items and Constructs of Standardized Health-Related Quality of Life and Mental Well-Being Measures

    Apr 1, 2024, 00:00

  • Cost and Utility Estimates per Modified Rankin Scale Score up to 2 Years Post Stroke: Data to Inform Economic Evaluations From a Societal Perspective

    Apr 1, 2024, 00:00

  • Benefit-Harm Analysis for Informed Decision Making on Participating in Colorectal Cancer Screening: A Modeling Study

    Apr 1, 2024, 00:00

  • Discrete Event Simulation to Incorporate Infusion Wait-Time When Assessing Cost-Effectiveness of a Chimeric-Antigen Receptor T Cell Therapy

    Apr 1, 2024, 00:00

  • A Review of Meaningful Change Thresholds for EORTC QLQ-C30 and FACT-G Within Oncology [Editor's Choice]

    Apr 1, 2024, 00:00

  • Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients [Editor's Choice]

    Apr 1, 2024, 00:00

  • Partial Orphan Cancer Drugs: US Food and Drug Administration Approval, Clinical Benefit, Trials, Epidemiology, Price, Beneficiaries, and Spending [Editor's Choice]

    Apr 1, 2024, 00:00

  • Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective

    Mar 1, 2024, 00:00

  • Scoring the Value Assessment Framework for China: A Factorial Survey

    Mar 1, 2024, 00:00

  • Financial Characteristics of Outcomes-Based Agreements: What Do Canadian Public Payers and Pharmaceutical Manufacturers Prefer?

    Mar 1, 2024, 00:00

  • Identifying the Optimum Strategy for Identifying Adults and Children With Celiac Disease: A Cost-Effectiveness and Value of Information Analysis

    Mar 1, 2024, 00:00

  • Are Manufacturing Patents to Blame for Biosimilar Market Launch Delays?

    Mar 1, 2024, 00:00

  • Work Productivity Among Younger Breast Cancer Survivors: The Impact of Behavioral Interventions for Depression

    Mar 1, 2024, 00:00

  • Table of Contents

    Mar 1, 2024, 00:00

  • Quantifying the Value of Reduced Health Disparities: Low-Dose Computed Tomography Lung Cancer Screening of High-Risk Individuals Within the United States

    Mar 1, 2024, 00:00

  • Unanchored Population-Adjusted Indirect Comparison Methods for Time-to-Event Outcomes Using Inverse Odds Weighting, Regression Adjustment, and Doubly Robust Methods With Either Individual Patient or Aggregate Data [Editor's Choice]

    Mar 1, 2024, 00:00

  • Patient Welfare Implications of Indication-Specific Value-Based Pricing of Multi-Indication Drugs [Editor's Choice]

    Mar 1, 2024, 00:00

  • Perils of Randomized Controlled Trial Survival Extrapolation Assuming Treatment Effect Waning: Why the Distinction Between Marginal and Conditional Estimates Matters [Editor's Choice]

    Mar 1, 2024, 00:00

  • Modeling Thyroid Cancer Epidemiology in the United States Using Papillary Thyroid Carcinoma Microsimulation Model

    Mar 1, 2024, 00:00

  • Logical Inconsistencies in the Health Years in Total and Equal Value of Life-Years Gained [Editor's Choice]

    Mar 1, 2024, 00:00

  • Drug Pricing, Patient Welfare, and Cost-Effectiveness Analysis

    Mar 1, 2024, 00:00

  • Using the Online Elicitation of Personal Utility Functions Approach to Derive a Patient-Based 5-Level Version of EQ-5D Value Set: A Study in 122 Patients With Rheumatic Diseases From Germany

    Mar 1, 2024, 00:00

  • Editorial Board

    Feb 26, 2024, 08:32

  • Table of Contents

    Feb 1, 2024, 00:00

  • Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States

    Feb 1, 2024, 00:00

  • Cost-Effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer in the United States

    Feb 1, 2024, 00:00

  • Patient Preferences in Pulmonary Arterial Hypertension, a Latent Class Analysis to Identify Preference Heterogeneity

    Feb 1, 2024, 00:00

  • Establishing Meaningful Change Thresholds in Patient-Reported Outcomes Among Patients With Anaplastic Lymphoma Kinase-Positive Non–Small Cell Lung Cancer in ALTA-1L Trial

    Feb 1, 2024, 00:00

  • The Health Inequality Impact of a New Cancer Therapy Given Treatment and Disease Characteristics

    Feb 1, 2024, 00:00

  • Applying Trial-Derived Treatment Effects to Real-World Populations: Generalizing Cost-Effectiveness Estimates When Modeling Complex Hazards [Editor's Choice]

    Feb 1, 2024, 00:00

  • Emulating Trials and Quantifying Bias: The Convergence of Health Technology Assessment Agency Real-World Evidence Guidance

    Feb 1, 2024, 00:00

  • Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study

    Feb 1, 2024, 00:00

  • Author Reply

    Feb 1, 2024, 00:00

  • How Well Does the EQ-5D-Y-5L Describe Children With Intellectual Disability?: “There’s a Lot More to My Child Than That She Can’t Wash or Dress Herself.”

    Feb 1, 2024, 00:00

  • Microsimulation Models on Mental Health: A Critical Review of the Literature [Editor's Choice]

    Feb 1, 2024, 00:00

  • Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report

    Feb 1, 2024, 00:00

  • Influence of Self-Reported Health Impairments on German EQ-5D-5L Values

    Feb 1, 2024, 00:00

  • Economic Burden and Service Utilization of Children With Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis

    Feb 1, 2024, 00:00

  • Patient-Reported Outcome-Based Performance Measures in Alternative Payment Models: Current Use, Implementation Barriers, and Principles to Succeed [Editor's Choice]

    Feb 1, 2024, 00:00

  • Editorial Board

    Jan 23, 2024, 09:13

  • Editorial Board

    Jan 9, 2024, 12:13

  • Assessing the Content Validity of Preference-Based Measures in Cancer

    Jan 1, 2024, 00:00

  • Appropriate Categorization of Inequality to Inform Policy Decisions: Estimating Distribution of Lifetime Health Using Alternative Approaches to Socioeconomic Stratification [Editor's Choice]

    Jan 1, 2024, 00:00

  • This Dead or That Dead: Framing Effects in the Evaluation of Health States

    Jan 1, 2024, 00:00

  • A Scoping Review and Taxonomy of Epidemiological-Macroeconomic Models of COVID-19

    Jan 1, 2024, 00:00

  • Multicriteria Decision Analysis and Value Assessment Frameworks: Where Do We Stand? What Next? [Editor's Choice]

    Jan 1, 2024, 00:00

  • Remembering Victor R. Fuchs, the “Dean” of Health Economics

    Jan 1, 2024, 00:00

  • Evaluation of Flexible Parametric Relative Survival Approaches for Enforcing Long-Term Constraints When Extrapolating All-Cause Survival [Editor's Choice]

    Jan 1, 2024, 00:00

  • Central Venous Access Devices for the Delivery of Systemic Anticancer Therapy: An Economic Evaluation

    Jan 1, 2024, 00:00

  • Two Methods, One Story? Comparing Results of a Choice Experiment and Multidimensional Thresholding From a Clinician Preference Study in Aneurysmal Subarachnoid Hemorrhage [Editor's Choice]

    Jan 1, 2024, 00:00

  • Analyzing Pragmatic Trials to Inform Cost-Effectiveness Analyses

    Jan 1, 2024, 00:00

  • Multistakeholder Perceptions of Additional Value Elements for United States Value Assessment of Health Interventions [Editor's Choice]

    Jan 1, 2024, 00:00

  • Negative Drug Pricing in the Context of Cost-Effectiveness Analysis: A Consistency Examination

    Jan 1, 2024, 00:00

  • Testing 2 Alternative Time Trade-Off Methods for Valuation of Children’s Health States

    Jan 1, 2024, 00:00

  • Copyright/Subscription

    Jan 1, 2024, 00:00

  • Table of Contents

    Jan 1, 2024, 00:00

  • Best Practices for the Electronic Implementation and Migration of Patient-Reported Outcome Measures

    Jan 1, 2024, 00:00

  • Characteristics of Prescription Drug Fills Using Pharmacy-Pharmacy Benefit Manager Discount Programs: The “GoodRx” Model

    Jan 1, 2024, 00:00

  • Economic Evaluations of Screening Programs for Chronic Kidney Disease: A Systematic Review

    Jan 1, 2024, 00:00
  • «
  • 11
  • 12
  • 13 (current)
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • »